CCND1 and malignant colon neoplasm: In the present study, our aim was to test the chemopreventive activity of the betanin/capecitabine combination in a model of chemically induced colon cancer and explore the possible inhibition of NFκB signaling and cyclin D1 protein using bioinformatic tools.